Stock 27F0 KALA BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases KALA BIO, Inc. Deutsche Boerse AG

Equities

27F0

US4831192020

Real-time Estimate Tradegate
Other stock markets
 11:38:30 01/07/2024 BST 		5-day change 1st Jan Change
6.7 EUR +8.24% Intraday chart for KALA BIO, Inc. +30.50% -2.04%
06-28 KALA BIO, Inc. announced that it has received $12.499192 million in funding from Baker Bros. Advisors LP, ADAR1 Capital Management, LLC, SR One Capital Management, LP CI
06-27 Top Midday Gainers MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
KALA BIO Announces $12,500,000 Private Placement
AQ
KALA BIO : Corporate Overview - June 2024
PU
KALA BIO to Present at Jefferies Global Healthcare Conference
AQ
KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update
AQ
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
AQ
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
AQ
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
AQ
KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
AQ
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update
AQ
KALA BIO Reports Inducement Grants under Nasdaq Listing Rule 5635(4)
AQ
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference
AQ
KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update
AQ
KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update
AQ
Kala Pharmaceuticals : Certificate of Incorporation/Bylaws - Form 8-K
PU
KALA BIO to Participate in Upcoming Investor Conferences in August
AQ
Kala Pharmaceuticals Announces Name Change to KALA BIO
AQ
Kala Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(4)
AQ
Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KALA Stock
  4. 27F0 Stock
  5. News KALA BIO, Inc.
  6. Press Releases